PMI — Picard Medical, Inc.
AMEX · Healthcare · Medical Devices
$4.08
+$0.22 (+5.61%)
Picard Medical, Inc. (PMI) is a medical devices company listed on AMEX. It is led by Patrick N. J. Schnegelsberg, based in 1992 East Silverlake Road, Tucson, AZ, United States, 85713, with about 75 employees. Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Latest reported PMI revenue for 2026-06-30 was $3.0M. Net income was -$5.7M. Revenue was up 156.9% from 2026-03-31 to 2026-06-30. PMI currently screens at market cap $16.9M.
Use this PMI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PMI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PMI SEC filings page. Lician reads the product cache first so this HTML stays unique to Picard Medical, Inc. even when a live quote feed is slow.
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
PMI Key Statistics
Market Cap
$16.90M
Volume
40.98M
Previous Close
$5.13
Day Range
$5.84 – $11.13
P/B Ratio
3.89
EPS
-$0.75
Revenue
$4.94M
Net Income
-$27.00M
Gross Profit
-$204.00K
Free Cash Flow
$0.00
Revenue Growth
+12.5%
Profit Margin
-546.6%
Debt to Equity
0.00
Employees
75
PMI Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.94M | $4.39M |
| Cost of Revenue | $5.14M | $4.50M |
| Gross Profit | -$204.00K | -$112.00K |
| Operating Income | -$13.26M | -$13.71M |
| Net Income | -$27.00M | -$21.05M |
| EPS (Diluted) | -$0.75 | -$2.99 |
Total Assets
$22.55M
Total Debt
$0.00
Shareholders' Equity
$3.79M
Cash & Equivalents
$7.45M
Operating Cash Flow
-$15.67M
Free Cash Flow
$0.00
Picard Medical, Inc. Company Information
- CEO & Director
- Patrick N. J. Schnegelsberg
- Headquarters
- 1992 East Silverlake Road, Tucson, AZ, United States, 85713
- Website
- www.picardmedical.com
- Phone
- 520 545 1234
- IPO / Founded
- 2025-08-29
- Sector
- Healthcare
- Industry
- Medical Devices